Commentary on ‘AAA with a Challenging Neck: Early Outcomes Using the Endurant Stent-graft System’  by Cieri, E. & De Rango, P.
at SciVerse ScienceDirect
European Journal of Vascular and Endovascular Surgery 44 (2012) 280Contents lists availableEuropean Journal of Vascular and Endovascular Surgery
journal homepage: www.ejves.comInvited Commentary
Commentary on ‘AAA with a Challenging Neck: Early Outcomes Using the
Endurant Stent-graft System’
E. Cieri*, P. De Rango
Vascular and Endovascular Surgery Unit, University of Perugia, Perugia, ItalyLatest generation devices for endovascular aortic repair (EVAR)
are raising an increasing interest due to the possibility to extend
effective treatment to aneurysm anatomies judged unfeasible by
endovascular route in the past. The Endurant Medtronic stent graft
has been introduced as an improved device to manage abdominal
aortic aneurysms (AAAs) with difﬁcult necks. In this issue of EJVES,
Setacci et al. showed that the Endurant can also work well on really
adverse neck anatomies using compelled off-label indications such
as short neck length <15 mm associated with >60 neck angle,
signiﬁcant thrombus or conical neck. Despite the adverse anatomy,
the authors did not ﬁnd higher perioperative complication rates or
increase in operative time and radiation exposure in the 72 repairs
performed for challenging aneurysm neck morphology with
respect to Endurant devices deployed in a control group of 65
patients treated with a more conservative morphology approach
following device-speciﬁc instruction for use. Technical success was
achieved in 100% of the 72 repairs with off-label indications and
there was no operative death or perioperative type I or III endoleak.
Even though supported by small numbers and non-consecutive
series of patients, these data certainly add valuable information to
other recent, multi- or single-centre published results on the safety
and feasibility of Endurant. Nevertheless, the short time of outcome
assessment (results from Setacci et al. were provided at only 1
month after repair) raises the concern as to whether the compelled
indications may provide durable efﬁcacy in aneurysm exclusion by
EVAR with Endurant. The main problem with endovascular
approach to AAA remains the efﬁcacy over time since EVAR is
demonstrated as a less durable procedure than open surgery often
requiring multiple re-interventions to maintain effective aneurysm
sac exclusion. Increasing data are supporting higher aneurysm
rupture and enlargement risks after EVAR with liberal aneurysm
morphology indications, outside speciﬁc instruction for use
established by the manufacturer.1 Without midelong-termDOI of original article: 10.1016/j.ejvs.2012.04.031.
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experience, forcing new generation devices in extremely adverse
aneurysm morphology might increase the risk of late failure even
with the new device.
Compelled morphology indications for EVAR with new gener-
ation devices are particularly useful in high-surgical risk patients
who cannot afford the risk of open surgery, when the life expec-
tancy remains long enough to deserve AAA treatment. However,
the deﬁnition of high-surgical risk patients to be forced to EVAR
treatment remains indeterminate and non-standardised. Setacci
et al. used a number of demographic and co-morbidity factors:
>80 y age, ejection fraction <25%, hostile abdomen, serum creati-
nine >2.0 mg dl1, forced expiratory volume <1 l s1. However,
about 20% of their patients were classiﬁed with an ASA score of II or
less (81% ASA III/IV) and probably only a local factor represented
a relative contraindication for open repair. There is the need to
uniform deﬁnition of risk criteria for patients with AAA to avoid
forcing to EVAR adverse aneurysm anatomy with high likelihood of
late failure also with most advanced devices.
Endurant device is a paradigm as new generation aortic devices
allowed notable improvements (in terms of expanded feasibility
and decreased complication rates with related higher durability)
for treatment of AAA. Nevertheless, as of today, optimistic
enthusiasm to reliably and deﬁnitely manage very challenging
aortic neck morphology by EVAR is still supported by limited
evidence and needs to be reinforced by more robust and longer
assessment data.Reference
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